SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001181431-09-006274
Filing Date
2009-02-03
Accepted
2009-02-03 18:38:06
Documents
2
Period of Report
2009-01-30

Document Format Files

Seq Description Document Type Size
1 FORM 3 rrd231411.html 3  
1 FORM 3 rrd231411.xml 3 1565
2 POWER OF ATTORNEY rrd207402_234375.htm EX-24. 2719
  Complete submission text file 0001181431-09-006274.txt   6254
Mailing Address 1003 W. CUTTING BLVD SUITE 110 POINT RICHMOND CA 94804
Business Address 1003 W. CUTTING BLVD SUITE 110 POINT RICHMOND CA 94804 (510) 215-3500
Transcept Pharmaceuticals Inc (Issuer) CIK: 0001178711 (see all company filings)

IRS No.: 330960223 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O INTERWEST PARTNERS 2710 SAND HILL ROAD, 2ND FLOOR MENLO PARK CA 94025
Business Address 650 854 8585
Ehrlich Christopher B (Reporting) CIK: 0001293973 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-51967 | Film No.: 09566310